Cancer nanomedicine: Is targeting our target?
- PMID: 27668091
- PMCID: PMC5034892
- DOI: 10.1038/natrevmats.2016.69
Cancer nanomedicine: Is targeting our target?
Abstract
Nanomedicine may have a delivery problem. Rigorous, realistic and holistic rethinking is needed to improve nanomedicine performance and increase patient benefit.
Conflict of interest statement
statement: The authors declare no competing interests.
References
-
- Wilhelm S, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1:16014.
-
- Lammers T, Rizzo LY, Storm G, Kiessling F. Personalized nanomedicine. Clin Cancer Res. 2012;18:4889–4894. - PubMed
-
- Tietjen GT, Saltzman WM. Nanomedicine gets personal. Sci Transl Med. 2015;7:314fs47. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources